# Chapter 6: Implementation Roadmap

**36-Month Execution Plan from MVP to $10M ARR**

---

## TL;DR

**Timeline**: 36 months (Pre-Launch → Foundation → Scale → Profitability)
**Team Growth**: 5 people (Month 0) → 50 people (Month 36)
**Revenue Growth**: $0 → $10M+ ARR
**Key Phases**: MVP (Q1), Pilots (Q2-Q4), Scale (Year 2), Optimize (Year 3)
**Critical Path**: Must complete Tier 0 features (auth, billing, support) before Tier 1 (product features)
**Go/No-Go Gates**: Quarterly milestones with success criteria (proceed or pivot)

---

## Implementation Philosophy

### Agile & Iterative

- Build MVP first, gather feedback, iterate quickly
- 2-week sprints with clear deliverables
- Weekly demos to stakeholders (CEO, advisors, pilot partners)

### Dependency-Driven

- Build foundation first (Tier 0: auth, billing, infrastructure)
- Then core product (Tier 1: mobile, telemedicine, testing)
- Then growth features (Tier 2: AI, research platform)
- Finally scale features (Tier 3: international, blockchain)

### Risk-Mitigated

- Front-load high-risk features (regulatory, technical complexity)
- Parallel workstreams where possible (e.g., iOS + Android simultaneously)
- Contingency buffer (10-15% of timeline for unexpected delays)

---

## Pre-Launch Phase (Months -3 to 0)

### Activities

**Fundraising**:

- Pitch 50+ seed investors (angels, micro-VCs, healthcare VCs)
- Goal: Raise $2.5M seed round
- Timeline: 3-6 months (parallel to incorporation)

**Company Formation**:

- Incorporate (Delaware C-Corp)
- Cap table setup (founders, advisors, ESOP pool)
- Banking, accounting, legal (Stripe Atlas, Carta, Cooley LLP)

**Team Hiring**:

- **CEO**: Healthcare entrepreneur (prior startup experience)
- **CTO**: Technical co-founder (HIPAA-compliant software expertise)
- **Medical Director**: Board-certified genetic counselor or geneticist

**Initial Planning**:

- Product roadmap (detailed specs for MVP)
- Go-to-market strategy (target customers, pitch deck)
- Partnerships (Quest/LabCorp labs, genetic counseling firms)

### Success Criteria (Go/No-Go Gate)

✅ $2.5M seed round closed
✅ 3-person founding team hired
✅ Legal entity formed, bank account funded
✅ Lab partnerships signed (Quest or LabCorp)

**If Fail**: Pivot to bootstrapped model (smaller scope) or delay launch

---

## Phase 1: Foundation (Q1 - Months 1-3)

### Team (5 → 8 people)

**Hires**:

- 2 Senior Engineers (full-stack, mobile)
- 1 Product Designer (UX/UI)
- Total: 8 people (3 founders + 5 hires)

**Budget**: $350K (payroll $250K + ops $100K)

### Features Built (Tier 0: Foundation)

**Authentication & Security**:

- User registration, login (OAuth 2.0, MFA)
- HIPAA-compliant data encryption (AES-256)
- Role-based access control (patient, provider, admin)

**Testing Workflow**:

- Test ordering (provider or patient-initiated)
- Lab integration (Quest/LabCorp API)
- Results delivery (encrypted, patient notification)

**Telemedicine Basic**:

- Video calls (Twilio Video API)
- Scheduling (calendar integration, Calendly)
- Session notes (genetic counselor documentation)

**Mobile App MVP**:

- iOS app (React Native): View test results, schedule counseling
- Android app (React Native): Same features as iOS

**Infrastructure**:

- AWS deployment (EC2, RDS PostgreSQL, S3)
- CI/CD pipeline (GitHub Actions, Docker)
- Monitoring (Datadog, PagerDuty)

### Partnerships & Pilots

**Lab Partnership**:

- Sign contract with Quest Diagnostics or LabCorp
- Negotiate pricing: $50/test (volume discount at 1K+ tests/year)

**Pilot Partners** (2 signed):

- Target: 2 self-insured employers (100-200 employees each)
- Outreach: CEO attends 3-5 conferences, 50+ cold emails
- Close rate: 4% (2 of 50 leads)

### Success Criteria (Q1 Go/No-Go Gate)

✅ MVP deployed to production
✅ 2 pilot partners signed ($300K contracted revenue)
✅ Lab partnership operational (can order tests)
✅ 1 genetic counselor hired (ready to deliver counseling)
✅ No critical security vulnerabilities (penetration test passed)

**If Fail**: Extend timeline 1-2 months OR reduce pilot scope (1 partner instead of 2)

---

## Phase 2: Core Product (Q2-Q3 - Months 4-9)

### Team (8 → 15 people)

**Hires**:

- VP Sales (Month 6): Enterprise sales experience, healthcare background
- 2 Genetic Counselors (Month 4, 6): Board-certified, telemedicine experience
- 2 Engineers (Month 5, 7): 1 backend, 1 mobile
- 1 QA Engineer (Month 8): Test automation, HIPAA compliance
- 1 Customer Success Manager (Month 9): Manage pilot partners

**Budget**: $900K (6 months, $450K payroll + $450K ops)

### Features Built (Tier 1: Core Product)

**Family Health Records**:

- Pedigree chart builder (3 generations)
- Cascade testing workflow (invite relatives)
- Family data sharing (with consent)

**Wearables Integration**:

- Apple HealthKit, Google Fit integration
- Sync heart rate, SpO2, steps, sleep
- Alerts for low oxygen levels (<90%)

**Educational Content**:

- CMS (Contentful) with 50+ articles/videos
- Topics: AATD 101, genetic testing, treatment options
- Mobile app integration (in-app content library)

**Community Forums**:

- Discussion boards (Discourse platform)
- Moderation by genetic counselors
- Private messaging between patients

**Provider Portal (V1)**:

- Web portal for providers to order tests
- View patient results (with consent)
- Care plan templates

### Pilot Execution

**Pilot 1 & 2 Launch** (Month 4-5):

- Member outreach: Co-branded emails, flyers
- Test ordering: 100-200 members invited, 40-50% sign up
- Testing: Blood draw at Quest/LabCorp
- Counseling: Pre-test + results delivery (30 min each)
- Care coordination: Refer to pulmonologists, AlphaNet

**Monthly Metrics**:

- Test uptake: 40%+ (40-80 tests per pilot)
- NPS: >60 (member satisfaction)
- Cost savings: Track early diagnoses (3-5 AATD patients identified)

### New Pilot Partners (3 more signed)

**Target**: 3 more self-insured employers or regional health plans
**Tactics**: Case studies from Pilots 1 & 2, conference presentations
**Total Pilots**: 5 (2 from Q1 + 3 from Q2-Q3)

### Success Criteria (Q2-Q3 Go/No-Go Gate)

✅ 5 pilot partners live (500+ members tested total)
✅ Mobile apps shipped to App Store / Play Store
✅ NPS >60 across all pilots
✅ 5-10 AATD patients diagnosed (prove clinical value)
✅ $1M ARR contracted (5 pilots × $150K avg + 2 renewals at $300K)

**If Fail**: Pause new sales, focus on existing pilot success (prove ROI before scaling)

---

## Phase 3: Growth (Q4 - Months 10-12)

### Team (15 people, steady state)

**No New Hires**: Focus on execution with current team

**Budget**: $600K (3 months)

### Features Built (Tier 1 Complete)

**Advanced Analytics**:

- Predictive models (FEV1 decline, hospitalization risk)
- Dashboards for patients (health trends)
- Dashboards for partners (program metrics)

**Customer Portal (Partner-Facing)**:

- Insurance partner dashboard (enrollment, outcomes, ROI)
- Self-service reporting (export data, generate case studies)

**EHR Integration (Beta)**:

- Epic FHIR API integration (pilot with 1-2 providers)
- Push genetic test results to EHR
- Bi-directional data sync (orders, results, notes)

### Pilot Renewals & Expansion

**Renew Pilots 1 & 2** (Month 12):

- Present Year 1 results: Test uptake, NPS, diagnosed patients, cost savings
- Upsell: Expand from pilot population (100-200) to full employee base (1K-5K)
- New pricing: $300K-400K/year (2-3× pilot price)

**Expand Pilots 3-5**:

- Continue execution, prepare for Month 18 renewals

**New Pipeline**:

- Generate 20-30 leads for Year 2 (conferences, case studies, referrals)

### Success Criteria (Q4 Go/No-Go Gate)

✅ 5 pilots completed (tested 500+ members)
✅ 2 pilot renewals signed ($600K-800K ARR for Year 2)
✅ Proven ROI: $3-5 saved for every $1 spent (early detection cost savings)
✅ Published case study (with pilot partner permission)
✅ $1.5M ARR total (5 pilots @ $150K avg + 2 renewals @ $300K avg)

**If Fail**: Re-evaluate pricing (too high?), product (missing features?), or GTM (wrong customers?)

---

## Phase 4-5: Scale (Year 2 - Months 13-24)

### Team (15 → 35 people)

**Key Hires**:

- VP Engineering (Month 13): Manage growing eng team
- VP Clinical (Month 15): Oversee genetic counseling quality
- 5 Engineers (Months 14-20): Backend, frontend, mobile, data, DevOps
- 3 Genetic Counselors (Months 13, 16, 19): Handle growing patient volume
- 5 Sales (Months 13-18): 2 AEs, 2 BDRs, 1 Sales Ops
- 3 CSMs (Months 14, 17, 20): 1 CSM per 3-4 partners
- 3 Marketing (Months 15-18): Content, growth, design
- 2 Operations (Months 16, 19): Finance/HR, compliance

**Budget**: $4.5M (12 months, $3.2M payroll + $1.3M ops)

### Features Built (Tier 2: Growth)

**Research Platform**:

- Patient registry database (10K patients by Year 2 end)
- Consent management (blockchain-based)
- Researcher portal (pharma partners access data)
- Real-world evidence generation

**AI Health Assistant**:

- Chatbot for common questions (OpenAI GPT-4)
- Symptom tracking recommendations
- Medication reminders

**Wearables Advanced**:

- Predictive alerts (ML models detect exacerbations before symptoms)
- Integration with 10+ devices (Apple Watch, Fitbit, Garmin, Oura, pulse oximeters)

**Provider Portal V2**:

- Full EHR integration (Epic, Cerner, Allscripts)
- Clinical decision support (recommend testing for high-risk patients)
- Referral network (connect to AATD specialists)

**International Readiness**:

- Multi-language support (Spanish, French)
- GDPR compliance (EU data residency)
- International lab partnerships (Canada, UK scoping)

### Partner Growth

**Renewals**: 5 of 5 Year 1 pilots renew (100% retention)
**Expansions**: 3 pilots expand to full member population
**New Partners**: 5 new partners signed (regional health plans)
**Total**: 10 partners by end of Year 2

**Revenue**: $4M ARR (10 partners × $350K avg + $500K pharma research)

### Pharma Partnerships

**Partner 1**: CSL Behring (Zemaira manufacturer)

- Clinical trial recruitment: $500K (recruit 50 patients for Phase 3 trial)

**Partner 2**: Vertex Pharmaceuticals (gene therapy pipeline)

- Natural history study: $300K (track 200 patients for 2 years)

**Total Pharma Revenue**: $800K Year 2

### Success Criteria (Year 2 Go/No-Go Gate)

✅ 10 insurance partners ($3.5M ARR)
✅ 2+ pharma partnerships ($500K+ ARR)
✅ 2,000+ patients tested (cumulative)
✅ Research platform launched (500+ patients in registry)
✅ NPS >70 (improving member experience)
✅ 90%+ partner retention

**If Fail**: Re-evaluate product-market fit, consider pivot or strategic acquisition

---

## Phase 6-7: Optimize & Profitability (Year 3 - Months 25-36)

### Team (35 → 50 people)

**Key Hires**:

- CFO (Month 30): Financial planning, Series B fundraising or profitability management
- VP Marketing (Month 26): Scale marketing, brand building
- 5 Regional Sales (Months 26-32): East, West, Central, South, National Accounts
- 5 Engineers (Months 26-34): Scale infrastructure, new features
- 2 Genetic Counselors (Months 28, 32): 7 total counselors
- 3 CSMs (Months 27, 30, 33): 1 CSM per 3-4 partners (need 6-7 total for 20 partners)

**Budget**: $9M (12 months, $6M payroll + $3M ops)

### Features Built (Tier 3: Scale & Optimize)

**Blockchain Privacy Layer**:

- Immutable audit trail of data access
- Patient-controlled consent ledger
- Smart contracts for data sharing agreements

**International Expansion**:

- Canada launch (PIPEDA compliance, Canadian labs)
- UK launch (GDPR, NHS partnerships)
- Multi-currency billing (CAD, GBP)

**Advanced Research Features**:

- Multi-site collaboration (academic institutions)
- External registry integration (AlphaNet, Alpha-1 Foundation)
- FHIR/OMOP data standardization (interoperability)

**Platform Scalability**:

- Kubernetes auto-scaling (handle 10K+ concurrent users)
- Multi-region deployment (US East, West, Canada, Europe)
- CDN optimization (Cloudflare, <100ms latency globally)

### Partner Growth

**Renewals**: 9 of 10 Year 2 partners renew (90% retention)
**Expansions**: 5 partners upsell (add features, expand population)
**New Partners**: 10 new partners (mix of self-insured, regional, 1-2 national plans)
**Total**: 20 partners by end of Year 3

**Revenue**: $8M ARR (20 partners × $400K avg)

### Pharma Partnerships (Scale)

**5 Pharma Partners**:

- CSL Behring, Grifols, Takeda, Vertex, Arrowhead
- **Services**: Clinical trials ($1M), natural history studies ($600K), RWE ($400K)

**Total Pharma Revenue**: $2M Year 3

### Profitability

**Revenue**: $10M ARR ($8M insurance + $2M pharma)
**Costs**: $9M (payroll $6M + ops $3M)
**Profit**: $1M (10% net margin)

**Milestone**: Reach profitability Month 36 (break-even Month 30)

### Success Criteria (Year 3 Exit/Next Phase)

✅ $10M+ ARR
✅ Profitable ($1M+ net income)
✅ 20 insurance partners (90%+ retention)
✅ 5 pharma partnerships
✅ 5,000+ patients tested (cumulative)
✅ Ready for Series B ($10M+ raise) OR strategic acquisition ($100M-300M valuation)

---

## Dependency Matrix Summary

### Tier 0: Foundation (Must Build First)

- Authentication & Security
- Billing & Payments
- Customer Support Infrastructure
- Lab Integration (Quest/LabCorp)

**Timeline**: Q1 (Months 1-3)

### Tier 1: Core Product (Build After Tier 0)

- Mobile Apps (iOS/Android)
- Telemedicine Platform
- Family Health Records
- Wearables Integration
- Patient Analytics

**Timeline**: Q2-Q4 (Months 4-12)
**Dependency**: Requires Tier 0 complete

### Tier 2: Growth Features (Build After Tier 1 Stable)

- Research Platform
- AI Health Assistant
- Provider Portal + EHR Integration
- Advanced Analytics
- International Expansion Prep

**Timeline**: Year 2 (Months 13-24)
**Dependency**: Requires Tier 1 complete, 5+ partners live

### Tier 3: Scale & Optimize (Build After Product-Market Fit)

- Blockchain Privacy Layer
- International Launch (Canada, UK)
- Multi-Site Research Collaboration
- Platform Scalability (10K+ users)

**Timeline**: Year 3 (Months 25-36)
**Dependency**: Requires Tier 2 complete, 10+ partners, profitability path clear

---

## Key Milestones & Go/No-Go Gates

| Quarter       | Milestone             | Success Criteria                   | Risk/Contingency                         |
| ------------- | --------------------- | ---------------------------------- | ---------------------------------------- |
| **Q1**        | MVP Launch            | MVP deployed, 2 pilots signed      | If fail: Extend 1-2 months               |
| **Q2-Q3**     | Pilot Execution       | 5 pilots live, 500 tested, NPS >60 | If fail: Pause sales, fix product        |
| **Q4**        | Renewals              | 2 renewals, $1.5M ARR              | If fail: Re-evaluate pricing/product     |
| **Year 2 Q2** | Scale                 | 10 partners, $4M ARR, 2 pharma     | If fail: Consider pivot or acquisition   |
| **Year 2 Q4** | Path to Profitability | 10 partners retained, 2K patients  | If fail: Fundraise Series B OR cut costs |
| **Year 3 Q2** | Breakeven             | Revenue = costs ($7-8M)            | If fail: Extend timeline or cut burn     |
| **Year 3 Q4** | Profitable            | $10M ARR, $1M profit, 20 partners  | Success: Series B or exit opportunity    |

---

**Continue Reading**: [Chapter 7: Organization & Operations →](./07_ORGANIZATION_OPERATIONS.md)

**Previous Chapter**: [← Chapter 5: Go-to-Market Strategy](./05_GO_TO_MARKET.md)

**Back to**: [← Whitepaper Home](./README.md)
